| Literature DB >> 36246130 |
Carlos Farinha1,2, José Pedro Ferreira1, João Serrano3, Hélder Santos4, Bárbara Oliveiros5, Fernanda M Silva1, Márcio Cascante-Rusenhack6, Ana Maria Teixeira1.
Abstract
Evidence shows that physical exercise is important in maintaining an efficient immune system during ageing. However, there are few studies that test the impact of aquatic exercise programs on the immune system. This study aims to analyze the impact of different physical exercise programs in aquatic environment on the systemic hematological and inflammatory markers of community dwelling elderly. One hundred and two elderly were randomly allocated into four groups: a continuous aerobic exercise group (AerG) (n = 25, 71.44 ± 4.84 years); an interval aerobic exercise group (IntG) (n = 28, 72.64 ± 5.22 years); a combined exercise group (ComG) (n = 29, 71.90 ± 5.67 years); a control group (CG) (n = 20, 73.60 ± 5.25 years). The AerG, IntG and ComG participants took part in three different aquatic exercise programs over a 28-weeks period. The CG participants maintained their usual routines during the same time period. Blood samples were collected from all participants in order to access hematologic indicators, by means of cell count, and the inflammatory profile by ELISA. After 28 weeks, significant differences were found for several hematologic variables in the AerG, IntG and ComG with increases in mean corpuscular hemoglobulin (MCH), mean corpuscular hemoglobulin concentration (MCHC), and hemoglobulin (Hb). Decreases in TNF-α levels were found for all exercising groups. An increase in IL-10 levels, granulocytes to lymphocytes ratio (GLR) and a decrease in the TNF-α/IL-10 ratio, were found for the IntG. For the ComG decreases were also found for the TNF-α, IL-1ß/IL-1ra ratios. The present study suggests that aquatic exercise programs were able to improve the inflammatory profile of the participants. Those in the exercise intervention groups showed a shift towards lower pro-inflammatory levels while the non-exercising group showed the opposite behaviour. The IntG and the ComG aquatic exercise programs appeared to be more effective than the AerG program in decreasing chronic low-grade inflammation by mediating the production of higher levels of anti-inflammatory cytokines. However, the differences found between the exercising groups were small and may not have clinical significance.Entities:
Keywords: ageing; aquatic environment; hydrogymnastics; inflammageing; interleukins; physical exercise
Year: 2022 PMID: 36246130 PMCID: PMC9554228 DOI: 10.3389/fphys.2022.838580
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.755
FIGURE 1Allocation process for the different groups: Continuous aerobic group (AerG); Aerobic interval group (IntG); Combined group (ComG); Control group (CG).
Participant’s baseline characteristics by group.
| AerG ( | IntG ( | ComG ( | CG ( |
| |
|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |
| Morphological parameters | |||||
| Age (years) | 71.44 (4.8) | 72.64 (5.2) | 71.90 (5.7) | 73.60 (5.3) | 0.504 |
| Stature (m) | 1.58 (0.7) | 1.56 (0.7) | 1.57 (0.7) | 1.60 (0.9) | 0.331 |
| Body mass (kg) | 70.5 (8.1) | 71.3 (14.3) | 75.1 (11.0) | 75.5 (13.3) | 0.334 |
| BMI (kg/m2) | 28.20 (3.3) | 29.10 (4.8) | 30.80 (5.3) | 29.50 (5.8) | 0.272 |
| VF (%) | 11.0 (3.0) | 12.0 (3.0) | 13.0 (3.0) | 13.0 (6.0) | 0.128 |
| FM (%) | 38.9 (7.3) | 41.0 (6,7) | 40.3 (9.8) | 34.9 (10.9) | 0.134 |
| LBM (%) | 26.5 (4.3) | 24.5 (3.0) | 25.5 (4.3) | 27.7 (4.7) | 0.079 |
| Physical fitness tests | |||||
| 2min-ST (no of steps) | 80.9 (17.4) | 71.5 (16.5) | 81.6 (19.2) | 74.3 (18.9) | 0.069 |
| CSR-R (cm) | -0.5 (6.6) | -3.7 (10.6) | -3.5 (7.8) | -7.6 (9.7) | 0.099 |
| CSR-L (cm) | 0.6 (7.2) | -3.9 (9.9) | -5.8 (9.9) | -3.5 (7.3) | 0.054 |
| BS-R (cm) | -9.9 (10.4) | -11.9 (11.5) | -14.3 (9.7) | -16.6 (9.9) | 0.157 |
| BS-L (cm) | -14.4 (7.2) | -17.4 (8.6) | -21.0 (10.8) | -20.6 (10.7) | 0.056 |
| TUG (s) | 6.1 (1.1) | 7.4 (1.8) | 7.4 (3.0) | 6.8 (1.7) | 0.110 |
| 30s-CS (reps/30s) | 15.0 (3.0) | 13.0 (4.0) | 13.0 (3.0) | 15.0 (5.0) | 0.185 |
| 30s-AC (reps/30s) | 21.0 (6.0) | 17.0 (7.0) | 20.0 (5.0) | 19.0 (6.0) | 0.119 |
| HG-R (kg) | 22.0 (6.0) | 21.0 (9.0) | 21.0 (9.0) | 24.0 (9.0) | 0.411 |
| HG-L (kg) | 21.0 (6.0) | 20.0 (9.0) | 21.0 (9.0) | 21.0 (10.0) | 0.578 |
| Health parameters | N (%) | N (%) | N (%) | N (%) | |
| Regular medication | 23 (92%) | 27 (96%) | 26 (90%) | 19 (95%) | 0.768 |
| No alcohol and smoking habits | 22 (88%) | 25 (89%) | 26 (90%) | 19 (95%) | 0.772 |
| Allergies | 10 (40%) | 9 (32%) | 14 (48%) | 7 (35%) | 0.638 |
SD, standard deviation; AerG, continuous aerobic group; IntG, aerobic interval group; ComG, combined group; CG, control group; Hgt, height; Wgt, weight; BMI, body mass index; VF, visceral fat; FM, fat mass; LBM, muscle mass; 2min-ST, two-minute step test; CSR-R, chair sit and reach test - right; CSR-L, chair sit and reach test - left; BS-R, back scratch test-right; BS-L, back scratch test-left; TUG, timed up and go test; 30s-CS, chair stand test; HG-R, hand grip test-right; HG-L, hand grip test-left. Regular medications include: medication to control blood pressure, cholesterol and diabetes.
FIGURE 2Time line, periodization and characterization of the exercise programs.
Results of systemic hematological variables at baseline and after 28 weeks of intervention.
| AerG | IntG | ComG | CG | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M1 | M2 | Time (p) | M1 | M2 | Time (p) | M1 | M2 | Time (p) | M1 | M2 | Time (p) | Group (M1) | Group (M2) | |
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |||||||
| LEU (×103/μL) | 5.99 (1.17) | 6.04 (1.26) | 0.838 | 5.85 (1.22) | 6.34 (1.26) |
| 6.37 (1.37) | 6.65 (1.51) |
| 5.70 (1.30) | 5.95 (1.44) | 0.183 | 0.269 | 0.335 |
| LI (%) | 35.67 (7.57) | 36.28 (8.38) | 0.657 | 34.09 (7.54) | 32.76 (9.06) | 0.158 | 35.57 (8.19) | 34.00 (8.75) | 0.140 | 37.00 (8.23) | 35.17 (7.95) | 0.108 | 0.546 | 0.444 |
| MO (%) | 5.76 (2.16) | 5.88 (1.80) | 0.844 | 6.39 (2.38) | 6.29 (2.06) | 0.809 | 6.57 (1.95) | 6.21 (2.25) | 0.542 | 5.99 (2.01) | 5.74 (1.79) | 0.665 | 0.505 | 0.741 |
| GR (%) | 58.58 (8.11) | 57.84 (8.44) | 0.575 | 59.51 (8.45) | 61.23 (9.50) | 0.094 | 57.86 (9.12) | 59.79 (8.81) | 0.123 | 57.01 (8.97) | 59.23 (9.42) | 0.098 | 0.604 | 0.396 |
| LI# (×103/μL) | 2.13 (0.63) | 2.17 (0.55) | 0.707 | 2.00 (0.59) | 2.07 (0.66) | 0.213 | 2.26 (0.65) | 2.22 (0.66) | 0.554 | 2.06 (0.45) | 2.04 (0.49) | 0.741 | 0.529 | 0.676 |
| MO# (×103/μL) | 0.34 (0.14) | 0.36 (0.14) | 0.503 | 0.37 (0.16) | 0.39 (0.17) | 0.388 | 0.43 (0.16) | 0.41 (0.16) | 0.503 | 0.33 (0.13) | 0.27 (0.12) | 0.078 | 0.152 |
|
| GR# (×103/μL) | 3.51 (0.86) | 3.52 (1.03) | 0.920 | 3.47 (0.87) | 3.89 (1.04) |
| 3.71 (1.06) | 4.02 (1.27) |
| 3.32 (1.04) | 3.50 (1.16) | 0.236 | 0.822 | 0.259 |
| ERI (×103/μL) | 4.63 (0.30) | 4.53 (0.33) |
| 4.59 (0.40) | 4.46 (0.32) |
| 4.64 (0.27) | 4.53 (0.26) |
| 4.66 (0.42) | 4.62 (0.55) | 0.706 | 0.852 | 0.611 |
| Hb (g/dL) | 13.15 (0.80) | 13.23 (0.71) | 0.591 | 13.12 (1.07) | 13.27 (0.90) | 0.153 | 13.09 (0.77) | 13.38 (1.08) |
| 13.22 (0.62) | 13.45 (1.04) | 0.285 | 0.793 | 0.852 |
| Hct (%) | 41.66 (2.19) | 40.42 (2.21) |
| 41.65 (3.03) | 40.00 (2.54) |
| 42.02 (2.50) | 40.75 (2.56) |
| 42.20 (2.08) | 41.91 (2.72) | 0.555 | 0.897 | 0.073 |
| MCV (fL) | 90.22 (4.24) | 89.34 (4.07) |
| 90.82 (3.81) | 89.97 (3.86) |
| 90.75 (3.79) | 89.92 (3.84) |
| 91.00 (5.51) | 90.53 (5.03) | 0.068 | 0.932 | 0.822 |
| MCH (pg) | 28.46 (1.44) | 29.24 (1.60) |
| 28.60 (1.33) | 29.86 (1.47) |
| 28.29 (1.43) | 29.53 (1.72) |
| 28.54 (1.77) | 29.19 (2.10) | 0.092 | 0.868 | 0.477 |
| MCHC (g/dL) | 31.54 (0.84) | 32.73 (0.77) |
| 31.50 (0.71) | 33.20 (0.73) |
| 31.15 (0.64) | 32.83 (1.13) |
| 31.37 (0.51) | 32.09 (1.45) | 0.079 | 0.155 |
|
| RDW (%) | 12.86 (0.53) | 12.73 (0.49) | 0.109 | 12.88 (0.56) | 12.71 (0.72) | 0.158 | 13.23 (0.81) | 12.89 (0.78) |
| 12.85 (0.50) | 12.69 (0.58) | 0.202 | 0.078 | 0.681 |
| PL (×103/μL) | 197.44 (53.91) | 198.64 (63.90) | 0.467 | 191.75 (47.50) | 187.64 (46.18) | 0.190 | 212.00 (39.28) | 206.34 (42.46) | 0.347 | 182.10 (38.28) | 173.55 (38.57) | 0.079 | 0.134 | 0.056 |
| MPV (fL) | 8.72 (1.03) | 8.46 (0.83) |
| 8.70 (0.91) | 8.48 (0.84) |
| 9.02 (0.91) | 8.76 (0.75) |
| 8.42 (0.81) | 8.28 (0.75) | 0.058 | 0.149 | 0.154 |
| PLR ratio | 98.91 (32.19) | 95.05 (30.01) | 0.677 | 102.93 (35.01) | 96.33 (27.49) | 0.092 | 102.25 (35.63) | 101.18 (35.09) | 0.721 | 93.66 (30.84) | 90.39 (28.26) | 0.332 | 0.875 | 0.749 |
| GLR ratio | 1.77 (0.62) | 1.71 (0.61) | 0.530 | 1.88 (0.70) | 2.06 (0.82) |
| 1.78 (0.74) | 1.95 (0.78) | 0.103 | 1.67 (0.61) | 1.78 (0.64) | 0.247 | 0.610 | 0.365 |
| SII | 351.02 (147.93) | 347.65 (187.99) | 0.696 | 350.13 (117.95) | 373.89 (129.63) | 0.265 | 383.44 (185.45) | 409.24 (182.16) | 0.430 | 309.53 (142.73) | 311.83 (138.38) | 0.823 | 0.600 | 0.178 |
*Result obtained through T-Student test.
**Result obtained through Wilcoxon test.
†Results obtained through ANOVA e Tukey test.
††Results obtained through Kruskal Wallis e Bonferroni test.
Bold are intended to highlight the variables where statistically significant differences were found.
SD, standard deviation; AerG, continuous aerobic group; IntG, aerobic interval group; ComG, combined group; CG, control group; LEU, Leukocytes; LI, lymphocytes percentage; MO, monocytes percentage; GR, granulocytes percentage; LI#, lymphocytes gross value; MO#, monocytes gross value; GR#, granulocytes gross value; ERI, erythrocytes; Hb, hemoglobulin concentration; Hct, hematocrit; MCV, mean corpuscular volume; MCH, mean globular hemoglobulin; MCHC, mean corpuscular hemoglobulin concentration; RDW, erythrocytes distribution width; PL, platelets; MPV, mean platelet volume; PLR ratio, platelets to lymphocytes ratio; GLR, granulocytes to lymphocytes ratio; SII, systemic immune-inflammation index.
FIGURE 3Percentage of delta (%Δ) the difference post-pre intervention for the immune inflammation markers PLR ratio, GLR ratio and SII index.
Inflammatory markers levels at baseline and after 28 weeks of intervention.
| AerG | IntG | ComG | CG | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M1 | M2 | Time (p) | M1 | M2 | Time (p) | M1 | M2 | Time (p) | M1 | M2 | Time (p) | Group (M1) | Group (M2) | |
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |||||||
| IL-10 (pg/ml) | 18.45 (14.08) | 17.67 (15.30) | 0.514 | 28.55 (10.13) | 36.70 (6.85) |
| 28.15 (14.12) | 24.69 (10.04) | 0.127 | 20.32 (12.87) | 16.87 (9.10) | 0.054 |
|
|
| IL-1ra (pg/ml) | 76.93 (51.79) | 81.28 (58.52) | 0.757 | 89.30 (56.68) | 92.98 (69.54) | 0.585 | 104.69 (63.82) | 115.71 (67.19) | 0.157 | 121.77 (83.56) | 88.31 (59.96) |
| 0.179 | 0.220 |
| IL-1ß (pg/ml) | 30.05 (3.75) | 29.50 (3.31) | 0.443 | 35.04 (16.67) | 33.25 (17.15) | 0.117 | 27.98 (10.16) | 27.00 (14.27) | 0.064 | 25.39 (4.04) | 26.49 (4.24) |
|
|
|
| TNF-α (pg/ml) | 37.38 (21.07) | 28.65 (21.72) |
| 17.65 (11.13) | 14.27 (9.63) |
| 69.01 (28.82) | 52.89 (25.25) |
| 31.98 (16.75) | 32.59 (18.96) | 0.936 |
|
|
| TNF-α/IL-10 ratio | 5.00 (6.25) | 3.85 (5.66) | 0.056 | 0.89 (1.07) | 0.45 (0.52) |
| 2.55 (0.75) | 2.23 (0.93) | 0.125 | 3.18 (4.16) | 3.18 (3.13) | 0.351 |
|
|
| IL-1β/IL-1ra ratio | 0.63 (0.45) | 0.75 (0.79) | 0.657 | 0.67 (0.60) | 1.01 (1.98) | 0.982 | 0.42 (0.40) | 0.36 (0.32) |
| 0.35 (0.33) | 0.50 (0.38) | 0.053 |
| 0.097 |
*Result obtained through T-Student test.
**Result obtained through Wilcoxon test.
†Results obtained through ANOVA e Tukey test.
††Results obtained through Kruskal Wallis and Bonferroni test.
Bold are intended to highlight the variables where statistically significant differences were found.
SD, standard deviation; AerG, continuous aerobic group; IntG, aerobic interval group; ComG, combined group; CG, control group; IL-10, Interleukin 10; IL-1ra, interleukin 1; IL-1ß, interleukin 1 beta; TNF-α, tumor necrosis factor; TNF-α/IL-10, ratio between tumor necrosis factor e Interleukin 10; IL-1β/IL-1ra, ratio between interleukin 1 beta e interleukin 1.
FIGURE 4Percentage of difference post-pre intervention for cytokines IL-10, IL-1ra, IL-1β, TNF-α and inflammatory index TNFα-/IL-10, IL-1β/IL-Ira.